Terms: = Skin cancer AND TG, Thyroglobulin AND Treatment
116 results:
1. Short-term effectiveness and potential factors of ustekinumab based on real-world data in Chinese psoriasis patients.
Li X; Xie X; Li J; Hu J; Hu K; Tan M; Yang J; Deng S; Liu Y; Zhang M; Kuang Y; Chen J; Liao L; Zhu W
J Dermatolog Treat; 2024 Dec; 35(1):2321188. PubMed ID: 38531383
[TBL] [Abstract] [Full Text] [Related]
2. Development of erlotinib-loaded nanotransferosomal gel for the topical treatment of ductal carcinoma
Mangla B; Mittal P; Kumar P; Javed S; Ahsan W; Aggarwal G
Nanomedicine (Lond); 2024 Apr; 19(10):855-874. PubMed ID: 38440976
[TBL] [Abstract] [Full Text] [Related]
3. Indoloquinazoline alkaloids suppress angiogenesis and inhibit metastasis of melanoma cells.
Guo X; Fan A; Qi X; Liu D; Huang J; Lin W
Bioorg Chem; 2023 Dec; 141():106873. PubMed ID: 37734192
[TBL] [Abstract] [Full Text] [Related]
4. Generation and comparison of 3D dosimetric reference datasets for COMS eye plaque brachytherapy using model-based dose calculations.
Fletcher EM; Ballester F; Beaulieu L; Morrison H; Poher A; Rivard MJ; Sloboda RS; Vijande J; Thomson RM
Med Phys; 2024 Jan; 51(1):694-706. PubMed ID: 37665982
[TBL] [Abstract] [Full Text] [Related]
5. The efficacy and safety in radioactive iodine refractory thyroid cancer patients treated with sorafenib.
Ling Y; Xiong X; Luo J; Zou Q; Chen P; Pan L; Long M; Feng H; Ouyang W
Front Endocrinol (Lausanne); 2023; 14():1200932. PubMed ID: 37534207
[TBL] [Abstract] [Full Text] [Related]
6. Transitioning from a COMS-based plaque brachytherapy program to using eye physics plaques and plaque simulator treatment planning system: A single institutional experience.
Meltsner SG; Rodrigues A; Materin MA; Kirsch DG; Craciunescu O
J Appl Clin Med Phys; 2023 May; 24(5):e13902. PubMed ID: 36637797
[TBL] [Abstract] [Full Text] [Related]
7. Novel Antitumor Agents Based on Fluorescent Benzofurazan Derivatives and Mesoporous Silica.
Tudose M; Culita DC; Baratoiu-Carpen RD; Mitran RA; Kuncser A; Romanitan C; Popescu RC; Savu DI
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555305
[TBL] [Abstract] [Full Text] [Related]
8. Case Report: Baricitinib as an Alternative in the Maintenance Therapy for Macrophage Activation Syndrome Secondary to Nodular Panniculitis.
Yi G; Huang Z; Huang Z; Wang Y; Deng W; Zheng S; Li T
Front Immunol; 2022; 13():914265. PubMed ID: 35874753
[TBL] [Abstract] [Full Text] [Related]
9. How to design, fabricate, and validate a customized COMS-style eye plaque: Illustrated with a narrow-slotted plaque example.
Deufel CL; Dalvin LA; Qian J; Vaishnav B; Cutsinger JM; Wittich MN; Petersen IA
Brachytherapy; 2021; 20(6):1235-1244. PubMed ID: 34217602
[TBL] [Abstract] [Full Text] [Related]
10. A review of dosimetric impact of implementation of model-based dose calculation algorithms (MBDCAs) for HDR brachytherapy.
Yousif YAM; Osman AFI; Halato MA
Phys Eng Sci Med; 2021 Sep; 44(3):871-886. PubMed ID: 34142317
[TBL] [Abstract] [Full Text] [Related]
11. The transmembrane protein LRIG1 triggers melanocytic tumor development following chemically induced skin carcinogenesis.
Hoesl C; Fröhlich T; Posch C; Kneitz H; Goebeler M; Schneider MR; Dahlhoff M
Mol Oncol; 2021 Aug; 15(8):2140-2155. PubMed ID: 33786987
[TBL] [Abstract] [Full Text] [Related]
12. skin dendritic cells in melanoma are key for successful checkpoint blockade therapy.
Prokopi A; Tripp CH; Tummers B; Hornsteiner F; Spoeck S; Crawford JC; Clements DR; Efremova M; Hutter K; Bellmann L; Cappellano G; Cadilha BL; Kobold S; Boon L; Ortner D; Trajanoski Z; Chen S; de Gruijl TD; Idoyaga J; Green DR; Stoitzner P
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33408092
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of TG43 and Hounsfield Unit-based TG186 brachytherapy dose metrics in Oncentra Brachy for 100 patients receiving interstitial partial breast irradiation.
Howie A; Poder J; Brown R; Schreiber K; Bece A; Graham P; Chin YS
Brachytherapy; 2021; 20(3):655-663. PubMed ID: 33358142
[TBL] [Abstract] [Full Text] [Related]
14. Unusual metastases from differentiated thyroid cancers: A multicenter study in Korea.
Yoon JH; Jeon MJ; Kim M; Hong AR; Kim HK; Shin DY; Kim BH; Kim WB; Shong YK; Kang HC
PLoS One; 2020; 15(8):e0238207. PubMed ID: 32841270
[TBL] [Abstract] [Full Text] [Related]
15. Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody.
Matsuoka H; Hayashi T; Takigami K; Imaizumi K; Shiroki R; Ohmiya N; Sugiura K; Kawada K; Sawaki A; Maeda K; Ando Y; Uyama I
BMC Cancer; 2020 Jul; 20(1):656. PubMed ID: 32664888
[TBL] [Abstract] [Full Text] [Related]
16. Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in cancer Patients.
Basak EA; van der Meer JWM; Hurkmans DP; Schreurs MWJ; Oomen-de Hoop E; van der Veldt AAM; Bins S; Joosse A; Koolen SLW; Debets R; Peeters RP; Aerts JGJV; Mathijssen RHJ; Medici M
Thyroid; 2020 Jul; 30(7):966-973. PubMed ID: 32151195
[No Abstract] [Full Text] [Related]
17. Dosimetric comparison of the INTRABEAM and Axxent for intraoperative breast radiotherapy.
Shaikh MY; Tanny S
Brachytherapy; 2020; 19(2):234-240. PubMed ID: 31879239
[TBL] [Abstract] [Full Text] [Related]
18. Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner.
Shi LZ; Goswami S; Fu T; Guan B; Chen J; Xiong L; Zhang J; Ng Tang D; Zhang X; Vence L; Blando J; Allison JP; Collazo R; Gao J; Sharma P
Cancer Immunol Res; 2019 Nov; 7(11):1803-1812. PubMed ID: 31466995
[TBL] [Abstract] [Full Text] [Related]
19. Experimental validation of a new COMS-like 24 mm eye plaque for the treatment of large ocular melanoma tumors.
McCauley Cutsinger S; Forsman R; Corner S; Deufel CL
Brachytherapy; 2019; 18(6):890-897. PubMed ID: 31444131
[TBL] [Abstract] [Full Text] [Related]
20. Outcomes and Predictors of Response in Steroid-Refractory Acute Graft-versus-Host Disease.
Rashidi A; DeFor TE; Holtan SG; Blazar BR; Weisdorf DJ; MacMillan ML
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2297-2302. PubMed ID: 31325587
[TBL] [Abstract] [Full Text] [Related]
[Next]
